PFE Articles, Pfizer Inc. - From 01/23/24

Bristol Myers Squibb & Co (NYSE:BMY) and Exelixis Inc (NASDAQ:EXEL) revealed four-year follow-up results from a cancer study that compared o...

Bristol Myers Squibb & Co (NYSE:BMY) announced that Opdivo (nivolumab) plus Yervoy (ipilimumab) combination continued to demonstrate long-...

In the dynamic and fiercely competitive business environment, conducting a thorough analysis of companies is crucial for investors and industry ent...

On CNBC’s "Halftime Report Final Trades," Liz Young of BNY Mellon Investment Management named Health Care Select Sector SPDR Fund...

Amit Dagar, a former senior statistical program lead at Pfizer Inc (NYSE:PFE), has been found guilty of securities fraud by a federal jur...

Diabetes treatments such as Ozempic and Mounjaro became the blockbuster drugs of 2023 thanks to their popularity as weight-loss remedies. Prices fo...

Artificial intelligence startup Anthropic is developing a new feature for its chatbot, Claude, enabling it to analyze images.&n...

Tuesday, GSK plc (NYSE:GSK) announced to sell 300 million ordinary shares in Haleon plc (NYSE:HLN) at 326 pence per s...

On Tuesday, Cathie Wood-led Ark Invest made a significant move by selling $15.84 million worth of ProShares Bitcoin Strategy ETF (NYSE:BITO) units....

Medicare Part D beneficiaries facing rising drug costs received welcome news as changes brought about by the 2022 Inflation Reduction Act cap their...